Edwards Lifesciences upgraded at Evercore on upcoming 'topline inflection'

[Edwards Lifesciences facility in Draper, Utah, USA]
JHVEPhoto/iStock Editorial via Getty Images

* Evercore ISI upgraded Edwards Lifesciences (NYSE:EW [https://seekingalpha.com/symbol/EW]) to outperform from equalweight to outperform as it sees "a topline inflection around the corner."
* The firm set a price target of $88 (~15% upside based on Oct. 6 close).
* Analyst Vijay Kumar said that competition for the company has eased with Boston Scientific (BSX [https://seekingalpha.com/symbol/BSX]) exiting the transcatheter aortic valve replacement (TAVR) market and data from Medtronic's (MDT [https://seekingalpha.com/symbol/MDT]) SMART trial of its Evolut TAVR "did not create a major share shift in the market." He added that these two developments more than offset's Abbott's (ABT [https://seekingalpha.com/symbol/ABT]) entry into the market.
* Kumar noted that asymptomatic TAVR could boost the market given that a quarterly Evercore hospital survey showed that TAVR is ranked No. 3 on a procedure priority list and a recent call with key opinion leaders indicated 4%-5% growth could come from asymptomatic TAVR.
* He also wrote that the data from the PROGRESS trial examining TAVR as a treatment for moderate aortic stenosis due in 2026 could also boost shares.

MORE ON EDWARDS LIFESCIENCES

* Edwards Lifesciences: A Market Leader Stuck In 'Hold' Mode Despite Solid Growth [https://seekingalpha.com/article/4815476-edwards-lifesciences-stock-market-leader-stuck-hold-mode-despite-solid-growth]
* Edwards Lifesciences: Gradually Winning My Investment Heart [https://seekingalpha.com/article/4814619-edwards-lifesciences-gradually-winning-my-investment-heart]
* Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4804339-edwards-lifesciences-corporation-ew-q2-2025-earnings-call-transcript]
* Edwards Lifesciences launches $500M accelerated share buyback [https://seekingalpha.com/news/4487229-edwards-lifesciences-launches-500m-accelerated-share-buyback]
* FTC sues to block Edwards Lifesciences purchase of JenaValve [https://seekingalpha.com/news/4480276-ftc-sues-to-block-edwards-lifesciences-purchase-of-jenavalve]